Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Scientists identified the mechanism by which a sea cucumber molecule inhibits sulfatase-2, an enzyme that’s often upregulated ...

The best way to ensure consistency as bioassays are transferred among labs and scaled up is to plan early on for those ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

The advancement of low input and single-cell transcriptomics and genomics techniques allows for the study of the dynamics of transcriptional and epigenetic regulation during the early stages of ...

The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...

The Tulane team has developed a handful of other assays for TB detection, including a mass spec test for paucibacillary TB ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that is being commercialized by Nanopin Tech, and a non-sputum CRISPR-based lab ...

The medicines have dangerous potency levels, either too low to fight cancer effectively or so high such that they poison ...

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or ...

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...